Products
NCTM
NCTM is an injectable, moldable, and drillable synthetic bone void filler comprised of a unique blend of advanced ceramic materials. The state-of-the-art composition of NCTM is precisely fabricated to match the rate of bone resorption and formation. Calcium sulfate serves as a resorbable carrier for hydroxyapatite, while hydroxyapatite, known for its exceptional osteoconductive properties, promotes
bone ingrowth.
NCTM ‘s distinctive characteristics make it an ideal choice for both minimally invasive procedures and open surgeries requiring bone remodeling. With its versatility and efficacy, NCTM is set to revolutionize bone repair procedures, offering optimized outcomes for patients.
Pipeline Product
Conlis Globals clinical development program focuses on further developing NCTM’s properties, broadening clinical application areas and utilizing NCTM’s unique drug- releasing properties through the development of combination products that promote bone healing and avoid infections at the site of grafting.
Several different combinations with NCTM have been investigated to add osteoinductive properties, meaning the ability to actively stimulate bone healing. Among other things, the Company has conducted research in the form of preclinical candidates that have combined NCTM with bone morphogenic proteins (BMP) and Zoledronic acid.
Pipeline Product
Conlis Globals clinical development program focuses on further developing NCTM’s properties, broadening clinical application areas and utilizing NCTM’s unique drug- releasing properties through the development of combination products that promote bone healing and avoid infections at the site of grafting.
Several different combinations with NCTM have been investigated to add osteoinductive properties, meaning the ability to actively stimulate bone healing. Among other things, the Company has conducted research in the form of preclinical candidates that have combined NCTM with bone morphogenic proteins (BMP) and Zoledronic acid.
NanoCement as delivery vehicle
Our clinical and research teams are pioneering NanoCement as a groundbreaking drug delivery vehicle, specifically for treating bone injuries. This innovative product not only promotes bone healing but also reduces infection risks at graft sites. NanoCement can deliver a range of therapeutic agents, including antibiotics to prevent infections, growth-promoting factors to accelerate bone regeneration, and chemotherapeutics for targeted treatment of bone cancers. By combining advanced drug delivery with bone void filling, NanoCement offers a comprehensive solution that transforms orthopedic treatments, significantly enhancing patient outcomes and advancing medical science.
Biodegradable hardware devices for Orthopedic Applications
At Conlis Global, we are dedicated to transforming orthopedics with bio-resorbable hardware that dissolves naturally in the body. These advanced implants are designed for optimal healing and minimal inconvenience, eliminating the need for a second surgery to remove hardware. Ideal for fracture fixation, ligament reconstruction, and other procedures, our bio-resorbable implants offer superior performance and compatibility. By using these cutting-edge solutions, patients experience faster recovery and improved quality of life, marking a significant advancement in orthopedic care.
Innovative Bone Substitute Materials
Conlis' R&D team is developing cutting-edge Bone Substitute Materials that are injectable, self-setting, and macroporous. These osteoconductive graft substitutes fill voids in the skeletal system, including the extremities, spine, and pelvis. What distinguishes our materials is their ability to be gradually resorbed and replaced with natural bone, promoting optimal healing and recovery. By integrating advanced technology and bioengineering, we provide solutions that not only repair bone but also elevate the quality of orthopedic care, leading to significantly better patient outcomes.